Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
2021 · Journal of the American College of Cardiology · 131 citations
https://doi.org/10.1016/j.jacc.2021.04.102
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
453
Citations
2
h-index
2
i10-index
Vojtech Novotny is an academic researcher. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Diabetes Treatment and Management & Health Systems, Economic Evaluations, Quality of Life. The author has an h-index of 2, co-authored 2 publications.
Click to start Chat